A ROTEM method using APTT reagent and tissue factor as the clotting activators may better define bleeding heterogeneity in moderate or severe haemophilia A (part I: Study in plasma samples). Issue 171 (November 2018)

• Record Type: Journal Article
• Authors: He, Shu; Eelde, Anna; Petrini, Pia; Wallen, Håkan; Gabrielsson, Lena; Svensson, Jan; Blombäck, Margareta; Holmström, Margareta
• Is Part Of: Thrombosis research. Issue 171(2018)
• Page Start: 7
• Page End: 13
• Publication Date: 2018-11
• Subjects: Haemophilia A -- Bleeding heterogeneity -- ROTEM -- Clotting activator -- Coagulation profile; Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2018.09.041
• Languages: English
• ISSNs: 0049-3848

Abstract

Abstract: Bleeding heterogeneity observed in haemophilia A (HA) may attribute to that the available monitoring methods cannot appropriately reflect the coagulation profile. The present study aimed to develop a global approach by changing the clotting initiation way in rotational thromboelastometry (ROTEM) assay. ROTEM was run in Factor VIII (FVIII)-immune-depleted plasma to which different concentrations of recombinant VIII (rFVIII) had been added, and also in 31 patients with HA. The clotting activators were APTT reagent (1.2 × 10 −3 of the dose used in the original APTT method) and recombinant tissue factor (0.02 pmol/L). In FVIII-immune-depleted plasma spiked with rFVIII, maximum velocity of coagulation reliably mirrored the rFVIII levels. This dose-response disappeared after the samples were pre-incubated with an antibody against TFPI, protein S, activated prothrombin complex concentrate or rFVIIa known to favour the extrinsic activation. In the HA patients with FVIII 0–0.21 IU/mL, APTT and ROTEM outcomes varied in significant correlations to FVIII activity; however, this correlation became non-significant when only samples with FVIII 0–0.05 IU/mL were included. Conclusions: The decreased coagulation in HA mostly result from deficiency/absence of FVIII; other pro-/anti-thrombotic proteins are also influential. The multiple effects may cause a mismatch between bleeding phenotype and FVIII concentrations. The ROTEM assay with the clotting activators i.e., tiny doses of APTT reagent and TF are more effective than the original APTT method as regards the assay sensitivity to influence by VIII activity and also to that by other pro-/anti-thrombotic proteins, showing the whole coagulation picture behind the phenotypic heterogeneity in HA. Highlights: Coagulation in haemophilia A (HA) decreases due to FVIII deficiency; other pro-/anti-thrombotic proteins are also influential. An overall coagulation method is needed to detect the mismatch between the bleeding phenotype and FVIII activity in HA. This study has modified ROTEM method by using tiny doses of APTT reagent and rTF as the clotting activators. The modified ROTEM method may help to show whole coagulation picture behind the phenotypic heterogeneity in HA.